biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > British Columbia Securities Commission!!

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Feb 07, 2023 10:52pm

156 Views

Post# 35273520

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:British Columbia Securities Commission!!

Rathjen "bagged" the Chiesi deal? Really?

So what if Chiesi/Protalix have a billion dollar franchise with Fabry? Bioasis made its deal. Three million up front, and $138 million in milestones. That's what Bioasis got. That's for four LSDs, of which Fabry is only one.

So, poof, you're touting a multi-billion dollar drug and Bioasis managed to negotiate only $750,000 and $34.5 million in milestones, and you're trying to tell us how great a deal that was?

Poof, without xB3, Chiesi wouldn't have any access to the billions that they can get with CNS versions of those drugs. And they paid nothing for it. They wouldn't have those markets without Bioasis and Bioasis got diddly-squat for it.

Well, there's one good thing about your posts, poof. Read one of 'em and we don't need to waste our time on any more of 'em.

We've had enough of these deals.

Rathjen got a deal arranged where the current owners of xB3 would have ended up with only 6% of the resulting company the sharks would have had 75%.

Chiesi has access to billions upon billions in LSD revenue and they paid Bioasis $750,000 for each one, with $34.5 million all in.

Is anybody seeing a pattern here? She has established the value of xB3 as virtually nothing, while the licensees make billions.

The numbers don't lie.

jd

<< Previous

Bullboard Posts

Next >>

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal